Viewing Study NCT04677595

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:08 PM
Ignite Modification Date: 2026-01-18 @ 6:32 PM
Study NCT ID: NCT04677595
Status: COMPLETED
Last Update Posted: 2025-06-24
First Post: 2020-12-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Capmatinib in Chinese Adult Patients With Advanced Non-small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Small Cell Lung Cancer (NSCLC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non small cell lung cancer View
None Non small cell carcinoma View
None INC280 View
None capmatinib View
None NSCLC View
None MET mutation View
None MET exon14 View
None EGFTwt View
None ALK negative View
None Epidermal growth factor receptor wild type View